Search the Newsreel

Medtronic PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh Revenue Breakdown – BMFBOVESPA:MDTC34 – TradingView

This article provides a revenue breakdown for Medtronic PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (MDTC34) based on data from TradingView. It highlights that the "Rest of World" segment contributed the most to revenue, with BRL 97.70 billion last year. The content …

Quantinno Capital Management LP Trims Stake in Medtronic PLC $MDT

Quantinno Capital Management LP significantly reduced its stake in Medtronic PLC by 28.0% during the first quarter, selling 283,724 shares and now owning 730,567 shares valued at $63,304,000. Other institutional investors also adjusted their positions, and 82.06% of Medtronic's stock is held by institutional …

Medtronic PLC $MDT Stock Position Decreased by California State Teachers Retirement System

The California State Teachers Retirement System reduced its holdings in Medtronic (NYSE: MDT) by 2.5% in the first quarter of 2026, selling over 53,000 shares but still retaining a significant stake valued at $176.7 million. Despite this, Medtronic reported strong quarterly earnings and revenue, …

A Look at Medtronic PLC (MDT) After 3.2% Gain -- GF Value $100.0

Medtronic PLC (MDT) shares rose 3.2% today, currently priced at $86.88, significantly below its GF Value™ of $100.02, indicating it is 13.1% undervalued. The company has a GF Score™ of 73/100, suggesting above-average performance, with strong valuation but weak momentum. Insider selling and mixed …

Medtronic Stock Builds Momentum On AI, SPR Deal And Bullish Street

Medtronic (MDT) stock is gaining momentum due to several positive catalysts, including its $650M acquisition of SPR Therapeutics, the deployment of its new Touch Surgery Aide AI platform, and improving regulatory prospects for its renal denervation system. Wall Street analysts maintain a generally bullish …

Is Medtronic (MDT) Fairly Valued After Its Pediatric Cannula Recall?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Medtronic (MDT) is in focus after a voluntary Class II recall of its DLP One-Piece Pediatric Arterial Cannula, following two complaints about loose foreign material …

Medtronic (MDT) Completes $650 Million SPR Deal And Launches ViaVerte

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Medtronic (NYSE:MDT) has completed its US$650m acquisition of SPR Therapeutics. The company formally launched the ViaVerte system at ASPN 2026, expanding its pain therapy portfolio. The deal …

Medtronic PLC (MDT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Medtronic PLC (MDT), indicating a risk score of 9.76 and ranking 1st in the Healthcare Equipment & Supplies industry. It highlights the company's beta of 0.61, suggesting lower volatility compared to the S&P 500, and includes detailed …

Medtronic PLC (NYSE:MDT) Given Consensus Recommendation of "Moderate Buy" by Analysts

Analysts have issued a consensus "Moderate Buy" rating for Medtronic PLC (NYSE:MDT), with an average 12-month price target of $98.21, significantly above its current trading price of $83.12. The company recently surpassed quarterly earnings and revenue expectations and increased its quarterly dividend to $0.72 …

Medtronic (MDT) Stock May Be Fairly Valued As Shares Sit Near A 5 Year Low

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Medtronic stock is coming off a 5 year period where the share price has fallen about 25%, yet current checks suggest the shares sit …

Is Medtronic (MDT) Undervalued Following Its Pediatric Cannula Recall?

Medtronic (MDT) is currently in focus due to a voluntary Class II recall of its pediatric arterial cannula. Despite a recent recall, the stock is considered undervalued with a fair value of $90.37 per share, compared to its current price of $84.22. The company, …

Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know

Medtronic (MDT) recently saw its stock price rise by 1.21% to $84.22, outperforming the S&P 500's daily gain. The company's earnings per share are projected to increase by 10.32% to $1.39 for the upcoming report on September 1, 2026, with revenue expected to reach …

How Medtronic Plc. (MDT) Affects Rotational Strategy Timing

Medtronic Plc. (MDT) shows stable neutral readings in shorter time horizons, potentially signaling an easing of a long-term weak bias, according to Stock Traders Daily's AI analysis. The analysis identifies a mid-channel oscillation pattern and an exceptional 34.3:1 risk-reward setup targeting a 10.0% gain …

Medtronic stock steadies as diabetes and cardiac businesses underpin earnings

Medtronic's stock is stabilizing due to strong performance in its diabetes and cardiovascular segments, which are supporting overall earnings. The company has shown mid-single-digit revenue growth and maintains a healthy operating margin, driven by innovation in areas like insulin delivery systems and minimally invasive …

Medtronic PLC (MDT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article details the revenue breakdown for Medtronic PLC (MDT) by both business segments and geographical regions. It presents specific financial figures and proportions for categories like Cardiac Rhythm & Heart Failure, Surgical & Endoscopy, and Cranial & Spinal Technologies, as well as revenue …

MDT|Medtronic PLC|Kurs:87.160|Änderung %:+1.240

MDT|Medtronic PLC|Price:82.035|Chg%:+0.145

Medtronic PLC (MDT) shows stable fundamentals and high growth potential, with its valuation considered fairly valued within the Healthcare Equipment & Supplies industry. Analysts largely rate the stock as "Buy" with a target price of $98.22, suggesting an upside of over 19%. The company …

Medtronic Earnings Preview: What to Expect

Medtronic sign seen at its Irvine office_By Tada Images Galway, Ireland-based Medtronic plc (MDT) is a global healthcare technology company that develops and manufactures medical devices, software, and AI-powered solutions to treat more than 70 medical conditions. With a market capitalization of approximately $105.4 …

Medtronic (MDT) Unveils Touch Surgery Aide For Real Time AI In Operating Rooms

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Medtronic (NYSE:MDT) has introduced Touch Surgery Aide, a next generation real-time AI platform designed …

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Medtronic (NYSE: MDT) is set to unveil Touch Surgery™ Aide, an AI-native surgical computing platform, at the Society of Robotic Surgery 2026 Annual Meeting. This platform, built on NVIDIA infrastructure, enables real-time artificial intelligence during surgical procedures for enhanced decision support and integrates with …

Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors

In the latest close session, Medtronic (MDT) was down 1.13% at $82.35. The stock fell short of the S&P 500, which registered a gain of 0.89% for the day. Elsewhere, the Dow gained 0.74%, while the tech-heavy Nasdaq added 1.29%. Shares of the medical …

Medtronic PLC stock underperforms Tuesday when compared to competitors

Shares of Medtronic PLC (MDT) declined by 1.13% on Tuesday, closing at $82.35. This performance lagged behind the broader market, as the S&P 500 Index and the Dow Jones Industrial Average both saw gains. The stock is currently 22.55% below its 52-week high of …

Medtronic adds real-time AI to Hugo robot

Medtronic has developed a new real-time AI application, Instrument Exit Point (IEP), for its Hugo surgical robot, which has received FDA clearance. This application, running on the Touch Surgery Aide platform with Nvidia's infrastructure, will debut at the Society of Robotic Surgery meeting this …

Medtronic to announce financial results for its first quarter of fiscal year 2027

GALWAY, Ireland, July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, …

2026 Minnesota ORBIE Awards Recognize Minnesota’s Top Technology and Security Executives

Inspire Leadership Network Leading CIOs and CISOs honored for leadership, innovation, and business impact.Meet the 2026 Minnesota ORBIE Award Winners MINNEAPOLIS, July 20, 2026 (GLOBE NEWSWIRE) -- The 2026 Minnesota ORBIE Awards honored leading chief information officers (CIOs) and chief information security officers (CISOs) …

Medtronic (MDT) to Announce Q1 FY2027 Earnings on August 18

Medtronic (MDT) has announced it will release its financial results for Q1 FY2027 on August 18, 2026. According to GuruFocus, the stock is currently undervalued by 16.5% with a GF Value™ of $99.87 against a current price of $83.44, and holds a solid GF …

Medtronic to report Q1 FY2027 financial results on September 1, 2026

Medtronic plc announced it will release its financial results for the first quarter of fiscal year 2027 on September 1, 2026. The company will issue a news release with summary financial information at 5:45 a.m. Central Time, followed by a video webcast discussion at …

Medtronic sets Sept. 1 date for its next financial report

Medtronic (NYSE: MDT) has announced that it will report its financial results for the first quarter of fiscal year 2027 on Tuesday, September 1, 2026. The report, covering the quarter that ended July 31, 2026, will be released via a news release at 5:45 …

Medtech acquisitions: DePuy Synthes, Medtronic add to portfolios

DePuy Synthes has acquired Expanding Innovations Inc., strengthening its Spine portfolio with expandable implant technology for spine surgery, including the X-PAC TLIF, LLIF, and N-GAGE systems. Concurrently, Medtronic plc completed its acquisition of SPR Therapeutics, valuing it at $650 million, to expand its offerings …

Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad

Medtronic and Apollo Hospitals have partnered to open an 11-bed "ICU of the Future" at Apollo Hospitals, Jubilee Hills, Hyderabad. This advanced Intensive Care Unit integrates Medtronic's Acute Care & Monitoring technologies to enhance critical care infrastructure and foster collaboration between clinicians and technology …

Medtronic (MDT) Completes SPR Therapeutics Deal To Expand Non Opioid Pain Care

Medtronic (MDT) has finalized its acquisition of SPR Therapeutics, integrating a minimally invasive, non-opioid pain treatment into its diverse pain therapy portfolio. This strategic move aims to broaden Medtronic's offerings in pain care, particularly in peripheral nerve stimulation, aligning with the growing demand for …

How Medtronic’s (MDT) Targeted Device Recall and Earnings Beat Have Changed Its Investment Story

Medtronic completes $650M acquisition of SPR Therapeutics

Medtronic (NYSE: MDT) has finalized its $650 million acquisition of SPR Therapeutics, a company specializing in short-term peripheral nerve stimulation for pain management. This strategic move strengthens Medtronic's presence in the healthcare equipment industry by integrating SPR's FDA-cleared SPRINT PNS System, a non-opioid, non-surgical …

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Medtronic has completed its acquisition of SPR Therapeutics, Inc. for $650 million, integrating SPR's SPRINT® PNS System into its pain therapy portfolio. This expands Medtronic's offerings for chronic and acute pain management with a minimally invasive, non-opioid treatment that does not require a permanent …

Medtronic Adds 60-Day Pain Therapy Without Permanent Implant

Medtronic (NYSE: MDT) has completed its $650 million cash acquisition of SPR Therapeutics, adding the SPRINT® peripheral nerve stimulation (PNS) technology to its pain therapy portfolio. This acquisition expands Medtronic's offerings for minimally invasive, non-opioid treatments for chronic and acute pain, with clinical data …

Medtronic faces first trial in US hernia mesh injury cases

Medtronic's Covidien unit is facing its first jury trial in Boston over claims that its hernia-repair mesh implants caused injuries. The plaintiff, Larry Patterson, alleges a Symbotex mesh implant led to a bowel obstruction, while Medtronic argues the product worked as designed and other …